行情

LCI

LCI

Lannett Co
NYSE

实时行情|Nasdaq Last Sale

9.75
-0.30
-2.99%
盘后: 9.75 0 0.00% 17:50 01/17 EST
开盘
10.15
昨收
10.05
最高
10.34
最低
9.53
成交量
129.44万
成交额
--
52周最高
15.52
52周最低
5.16
市值
3.93亿
市盈率(TTM)
140.49
分时
5日
1月
3月
1年
5年

分析师评级

5位分析师的综合评级

中性

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

EPS

LCI 新闻

  • 特朗普公布弹劾案辩护团队 参议院审理流程一览
  • 中国新闻网.37分钟前
  • 美参院启动弹劾案 特朗普新聘三位律师
  • 央视.1小时前
  • 原英特尔FPGA负责人Dan McNamara加入AMD
  • TechWeb.1小时前
  • SpaceX最强火箭升空 特斯拉市值逼千亿
  • 投中网.1小时前

更多

所属板块

制药
+0.13%
制药与医学研究
+0.07%

热门股票

名称
价格
涨跌幅

LCI 简况

Lannett Company, Inc. develops, manufactures, markets and distributes generic versions of brand pharmaceutical products. The Company manufactures and/or distributes prescription products with the exception of a small portfolio of over-the-counter products manufactured by its subsidiary, Silarx Pharmaceuticals, Inc. As of June 30, 2016, the Company's products included Acetazolamide Tablets; Butalbital, Acetaminophen and Caffeine Tablets; Butalbital, Aspirin and Caffeine Capsules; C-Topical Solution; Digoxin Tablets; Glycolax Rx; Isosorbide Mononitrate CR; Levothyroxine Sodium Tablets; Methylphenidate HCL CD; Methylphenidate ER; Nifedipine CR; Omeprazole DR; Oxbutynin ER; Pantoprazole DR; Pilocarpine HCl Tablets; Triamterene w/Hydrochlorothiazide Capsules, and Ursodiol Capsules. The Company has additional products under development, which are orally administered solid oral-dosage products (tablet/capsule) or oral solutions, nasal, topicals or parentarels, as well as other dosage forms.
展开

Webull提供Lannett Company, Inc.的股票价格,实时市场报价,专业分析师评级,深度图表和免费的股票新闻,以帮助您做出投资决策。